PAW for Childhood Obesity
(PAW Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Pediatric weight management efficacy is impacted by failure to complete treatment protocols and, for those that do complete treatment, a return to unhealthy behaviors. This project tests whether treating pain, a common comorbid condition to pediatric obesity, will enhance treatment. This study will generate results that can be translated into immediate improvements in care for families seeking treatment for pediatric obesity.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on weight reducing medications.
Is the PAW treatment for childhood obesity safe for humans?
What data supports the effectiveness of the treatment PAW for Childhood Obesity?
The research suggests that pediatric weight management programs, which often include components like behavior therapy and increased physical activity, can improve health outcomes such as BMI (a measure of body fat based on height and weight) and cardiovascular risk factors in children. These elements are likely part of the PAW treatment, indicating potential effectiveness.678910
Who Is on the Research Team?
Melissa Santos, PhD
Principal Investigator
Connecticut Children's Medical Center
Are You a Good Fit for This Trial?
This trial is for English-speaking children aged 12-18 with obesity, experiencing musculoskeletal pain, and enrolled in a weight management program. They must score above 3 on the Pain Burden Inventory, indicating significant pain. Parents or guardians must consent to participate but can't join if they have Type 1 diabetes, are on weight loss meds, or have severe psychiatric issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Focus Group
A focus group will be held to review the PAW curriculum
Treatment
Participants undergo a 13-week Fit5 program with a 4-session adjunctive CBT intervention for those with musculoskeletal pain
Follow-up
Participants are monitored for safety and effectiveness after treatment
Exit Interviews
Exit interviews to obtain preliminary feasibility, acceptability, and retention data on PAW
What Are the Treatments Tested in This Trial?
Interventions
- Pain Education
- PAW
Find a Clinic Near You
Who Is Running the Clinical Trial?
Connecticut Children's Medical Center
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator